A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Entering the golden age for antibody-drug conjugates in gynecologic cancer.” In...
Patients with HER2-positive breast cancer showed benefit with T-DM1 treatment | Image Credit- Marina – stock.adobe.com Patients with stage I HER2-positive breast cancer had effective long-term...